HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michael Wang Selected Research

Gln(8)- LHRH

1/2011Luteinizing Hormone-Releasing Hormone (LHRH)-I antagonist cetrorelix inhibits myeloma cell growth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Michael Wang Research Topics

Disease

78Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
11/2022 - 02/2005
61Neoplasms (Cancer)
11/2022 - 05/2003
52Multiple Myeloma
01/2020 - 10/2003
21B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2005
17Hemophilia A (Haemophilia)
07/2022 - 01/2013
15Hemorrhage
07/2022 - 05/2003
15Lymphoma (Lymphomas)
01/2022 - 02/2005
11Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019 - 10/2004
9Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2021 - 02/2005
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 05/2013
8B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2022 - 02/2005
7Thrombosis (Thrombus)
10/2021 - 01/2002
7Infections
10/2021 - 07/2003
6Disease Progression
01/2020 - 10/2010
5Pain (Aches)
07/2022 - 11/2006
5Congenital Abnormalities (Deformity)
12/2021 - 10/2015
5Peripheral Nervous System Diseases (PNS Diseases)
08/2014 - 06/2009
5Venous Thromboembolism
10/2012 - 11/2007
4Thrombocytopenia (Thrombopenia)
01/2017 - 10/2012
4Neutropenia
01/2017 - 11/2007
3Residual Neoplasm
06/2022 - 01/2019
3Hodgkin Disease (Hodgkin's Disease)
01/2022 - 11/2006
3Thrombophilia
10/2021 - 06/2013
3Body Weight (Weight, Body)
01/2020 - 05/2016
3Dehydration (Water Stress)
01/2020 - 01/2019
3Neoplasm Metastasis (Metastasis)
01/2019 - 05/2007
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018 - 10/2010
3Hematologic Neoplasms (Hematological Malignancy)
01/2018 - 11/2011
3Carcinogenesis
01/2018 - 05/2003
3Fatigue
11/2017 - 08/2014
3Brain Neoplasms (Brain Tumor)
11/2013 - 05/2007
3Venous Thrombosis (Deep-Vein Thrombosis)
06/2013 - 02/2011
2Hypersensitivity (Allergy)
07/2022 - 11/2021
2Cardiotoxicity
01/2022 - 03/2015
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2022 - 06/2015
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022 - 06/2015
2Cytokine Release Syndrome
01/2022 - 01/2020
2Atrial Fibrillation
01/2022 - 12/2016
2Overweight
01/2022 - 01/2020
2Scoliosis
12/2021 - 12/2018

Drug/Important Bio-Agent (IBA)

25Rituximab (Mabthera)FDA Link
11/2022 - 10/2005
24Bortezomib (Velcade)FDA Link
11/2019 - 02/2005
23ibrutinibIBA
01/2022 - 06/2013
23Lenalidomide (CC 5013)FDA Link
01/2021 - 10/2007
19Agammaglobulinaemia Tyrosine KinaseIBA
10/2022 - 09/2014
17Dexamethasone (Maxidex)FDA LinkGeneric
01/2020 - 10/2003
14Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2003
14carfilzomibIBA
01/2020 - 06/2012
13Chimeric Antigen ReceptorsIBA
10/2022 - 01/2016
10Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2018 - 11/2008
9Cytarabine (Cytosar-U)FDA LinkGeneric
06/2022 - 10/2005
9Proteasome InhibitorsIBA
02/2017 - 02/2005
8Monoclonal AntibodiesIBA
12/2019 - 10/2006
7AntibodiesIBA
07/2022 - 04/2008
7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 11/2006
7Methotrexate (Mexate)FDA LinkGeneric
01/2018 - 10/2005
7Vincristine (Oncovin)FDA LinkGeneric
01/2018 - 11/2008
7Thalidomide (Thalomid)FDA Link
08/2014 - 10/2003
6Pharmaceutical PreparationsIBA
01/2022 - 11/2007
6Factor VIII (Coagulation Factor VIII)IBA
07/2021 - 02/2011
5venetoclaxIBA
11/2022 - 01/2018
5brexucabtagene autoleucelIBA
06/2022 - 01/2020
5zanubrutinibIBA
01/2022 - 01/2019
5AntigensIBA
01/2022 - 09/2007
5acalabrutinibIBA
11/2021 - 01/2018
4recombinant FVIIa (rFVIIa)FDA Link
07/2022 - 07/2013
4axicabtagene ciloleucelIBA
01/2022 - 01/2020
4Cyclin D1IBA
01/2019 - 02/2008
4Biomarkers (Surrogate Marker)IBA
10/2018 - 11/2013
4Biological ProductsIBA
01/2018 - 12/2016
4Prednisone (Sone)FDA LinkGeneric
01/2018 - 12/2013
4Antineoplastic Agents (Antineoplastics)IBA
02/2017 - 05/2012
4Proteasome Endopeptidase Complex (Proteasome)IBA
01/2016 - 07/2006
4Melphalan (Alkeran)FDA LinkGeneric
05/2012 - 12/2008
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 03/2011
3CytokinesIBA
01/2020 - 01/2018
3Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 01/2014
3azaspiraneIBA
03/2012 - 06/2007
2BESIBA
07/2022 - 01/2022
2Factor VII (Proconvertin)IBA
07/2022 - 11/2021
2Blood Coagulation Factors (Coagulation Factor)IBA
01/2022 - 01/2021
2CreatinineIBA
01/2022 - 07/2009
2emicizumabIBA
07/2021 - 12/2019
2ThrombinFDA Link
02/2021 - 01/2013
2Bendamustine HydrochlorideFDA Link
01/2021 - 11/2019
2factor VIII-Fc fusion proteinIBA
01/2021 - 10/2016

Therapy/Procedure

69Therapeutics
11/2022 - 02/2005
22Drug Therapy (Chemotherapy)
01/2022 - 10/2004
9Radiotherapy
05/2019 - 05/2007
8Immunotherapy
11/2022 - 09/2007
6Hematopoietic Stem Cell Transplantation
01/2016 - 12/2008
5Aftercare (After-Treatment)
09/2018 - 10/2005
4Decompression
12/2021 - 11/2010
4Minimally Invasive Surgical Procedures
07/2019 - 10/2017
4Stem Cell Transplantation
09/2014 - 09/2007
3Transplantation
06/2022 - 11/2010
2Cell Transplantation
12/2021 - 01/2021
2Length of Stay
12/2021 - 07/2019
2Perioperative Care
11/2021 - 11/2021
2Central Venous Catheters
10/2021 - 10/2017